Absence of transient receptor potential vanilloid-1 accelerates stress-induced axonopathy in the optic projection

Nicholas J Ward1, Karen W Ho, Wendi S Lambert

  • 1Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, Tennessee 37232-0654.

Insights

Transient Receptor Potential Vanilloid-1 (TRPV1) channels may protect neurons from stress in optic neuropathies like glaucoma. Deleting TRPV1 in mice accelerated vision loss and nerve damage from elevated eye pressure.

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Ion Channel Physiology

Background:

  • Neuronal stress responses are critical for understanding degenerative diseases and developing therapies.
  • Transient Receptor Potential (TRP) ion channels are implicated in mediating stress signals in physiological and pathological contexts.

Purpose of the Study:

  • To investigate the role of the TRP Vanilloid-1 (TRPV1) subunit in neuronal stress response within the optic projection.
  • To determine if TRPV1 influences the progression of optic neuropathy under elevated ocular pressure.

Main Methods:

  • Comparison of optic nerve stress response in Trpv1(-/-) mice and wild-type controls under induced elevated ocular pressure.
  • Assessment of axonal transport, nerve degeneration, and retinal ganglion cell survival.
  • Pharmacological antagonism of TRPV1 in rats subjected to elevated ocular pressure.
  • Electrophysiological recordings of retinal ganglion cells.

Main Results:

  • Trpv1(-/-) mice exhibited accelerated axonal transport degradation and optic nerve degeneration under elevated ocular pressure.
  • Retinal ganglion cell body loss occurred earlier in Trpv1(-/-) mice, specifically in nasal sectors.
  • Pharmacological TRPV1 blockade in rats also hastened axonopathy.
  • Elevated ocular pressure altered ganglion cell firing rates and action potential thresholds differently in Trpv1(-/-) versus control mice.

Conclusions:

  • TRPV1 may play a protective role in neuronal stress responses relevant to optic neuropathies.
  • TRPV1 activity appears necessary for maintaining axonal signaling under disease-relevant stress.
  • Targeting TRPV1 could offer a therapeutic strategy for conditions like glaucoma.